A strategy for cell-based multiplex diagnostics of Myasthenia gravis and autoimmune encephalitis by modifying the subcellular localization of cell membrane autoantigens

Clinical Hemorheology and Microcirculation

Volumn 58, Issue 1, 2014, Pages 211-228

  George, S ^a,b   Georgi, M ^a   Roggenbuck, D ^a,c   Conrad, K ^b   Kupper J H ^a  

^a BRANDENBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Generic Assays GmbH   (Germany)

Author keywords

AKLIDES; autoimmune diseases; encephalitis; immunofluorescence; intracellular trafficking; multiplex diagnostics; Myasthenia gravis

Indexed keywords

AUTOANTIGEN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; GREEN FLUORESCENT PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOTOPROTEIN; RECOMBINANT PROTEIN; RED FLUORESCENT PROTEIN;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE ENCEPHALITIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTODIAGNOSIS; CYTOPLASM; ENCEPHALITIS; GOLGI COMPLEX; HEP 2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INTRACELLULAR SIGNALING; LYSOSOME; MITOCHONDRION; MYASTHENIA GRAVIS; PROTEIN LOCALIZATION; PROTEIN TARGETING; WILD TYPE; BRAIN DISEASES; CELL MEMBRANE; CHEMISTRY; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; HASHIMOTO DISEASE; HEPG2 CELL LINE; IMMUNOLOGY; METABOLISM; PLASMID;

AUTOANTIGENS; BRAIN DISEASES; CELL MEMBRANE; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GOLGI APPARATUS; GREEN FLUORESCENT PROTEINS; HASHIMOTO DISEASE; HEP G2 CELLS; HUMANS; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; MYASTHENIA GRAVIS; PLASMIDS; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS;

EID: 84908239511     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-141897     Document Type: Article

References (59)

1. A. Boronat, L. Sabater, A. Saiz, J. Dalmau and F. Graus, GABA(B) receptor antibodies in limbic encephalitis and anti- GAD-Associated neurologic disorders, Neurology 76 (2011), 795-800
2. B.F. Bruner, J.M. Guthridge, R. Lu, G. Vidal, J.A. Kelly, J.M. Robertson, D.L. Kamen, G.S. Gilkeson, B.R. Neas, M. Reichlin, R.H. Scofield, J.B. Harley and J.A. James, Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members, Arthritis Rheum 64 (2012), 3677-3686
3. D.A. Collings, Subcellular localization of transiently expressed fluorescent fusion proteins, Methods Mol Biol 1069 (2013), 227-258
4. B.M. Conti-Fine, M. Milani and H.J. Kaminski, Myasthenia gravis: Past, present, and future, J Clin Invest 116 (2006), 2843-2854
5. J. Dalmau, A.J. Gleichman, E.G. Hughes, J.E. Rossi, X. Peng, M. Lai, S.K. Dessain, M.R. Rosenfeld, R. Balice-Gordon and D.R. Lynch, Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies, Lancet Neurol 7 (2008), 1091-1098
6. J. Dalmau, E. Tuzun, H.Y.Wu, J. Masjuan, J.E. Rossi, A. Voloschin, J.M. Baehring, H. Shimazaki, R. Koide, D. King, W. Mason, L.H. Sansing, M.A. Dichter, M.R. Rosenfeld and D.R. Lynch, Paraneoplastic anti-N-methyl-D-Aspartate receptor encephalitis associated with ovarian teratoma, Ann Neurol 61 (2007), 25-36
7. F. Deymeer, O. Gungor-Tuncer, V. Yilmaz, Y. Parman, P. Serdaroglu, C. Ozdemir, A. Vincent and G. Saruhan-Direskeneli, Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis, Neurology 68 (2007), 609-611
8. K. Egerer, D. Roggenbuck, R. Hiemann, M.G. Weyer, T. Buttner, B. Radau, R. Krause, B. Lehmann, E. Feist and G.R. Burmester, Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests, Arthritis Res Ther 12 (2010), R40
9. A. Evoli, M.R. Bianchi, R. Riso, G.M. Minicuci, A.P. Batocchi, S. Servidei, F. Scuderi and E. Bartoccioni, Response to therapy in myasthenia gravis with anti-MuSK antibodies, Ann N Y Acad Sci 1132 (2008), 76-83
10. A. Evoli, P.A. Tonali, L. Padua, M.L. Monaco, F. Scuderi, A.P. Batocchi, M. Marino and E. Bartoccioni, Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis, Brain: A Journal of Neurology 126 (2003), 2304-2311
11. S. George, S. Paulick, I. Knutter, N. Rober, R. Hiemann, D. Roggenbuck, K. Conrad and J.H. Kupper, Stable expression of human muscle-specific kinase in HEp-2 M4 cells for automatic immunofluorescence diagnostics of myasthenia gravis, PLoS One 9 (2014), e83924
12. G. Grassi, P. Maccaroni, R. Meyer, H. Kaiser, E. D'Ambrosio, E. Pascale, M. Grassi, A. Kuhn, N.P. Di, R. Kandolf and J.H. Kupper, Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87, Carcinogenesis 24 (2003), 1625-1635
13. M. Hansson, L. Mathsson, T. Schlederer, L. Israelsson, P. Matsson, L. Nogueira, P.J. Jakobsson, K. Lundberg, V. Malmstrom, G. Serre, R. Holmdahl, M. Nystrand, L. Klareskog and J. Ronnelid, Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides, Arthritis Res Ther 14 (2012), R201
14. L. Hicke and R. Dunn, Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins, Annu Rev Cell Dev Biol 19 (2003), 141-172
15. R. Hiemann, N. Hilger, J. Michel, J. Nitschke, A. Bohm, U. Anderer, M. Weigert and U. Sack, Automatic analysis of immunofluorescence patterns of HEp-2 cells, Ann N Y Acad Sci 1109 (2007), 358-371
16. W. Hoch, J. McConville, S. Helms, J. Newsom-Davis, A. Melms and A. Vincent, Auto-Antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies, Nat Med 7 (2001), 365-368
17. S.R. Irani, S. Alexander, P. Waters, K.A. Kleopa, P. Pettingill, L. Zuliani, E. Peles, C. Buckley, B. Lang and A. Vincent, Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-Associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia, Brain 133 (2010), 2734-2748
18. S.R. Irani and A. Vincent, Autoimmune encephalitis - new awareness, challenging questions, Discov Med 11 (2011), 449-458
19. T. Ishii, K. Moriyoshi, H. Sugihara, K. Sakurada, H. Kadotani, M. Yokoi, C. Akazawa, R. Shigemoto, N. Mizuno and M. Masu, Molecular characterization of the family of the N-methyl-D-Aspartate receptor subunits, J Biol Chem 268 (1993), 2836-2843
20. S.E. Kaiser, J.H. Brickner, A.R. Reilein, T.D. Fenn, P. Walter and A.T. Brunger, Structural basis of FFAT motif-mediated ER targeting, Structure 13 (2005), 1035-1045
21. S. Kivity, B. Gilburd, N. Agmon-Levin, M.G. Carrasco, Y. Tzafrir, Y. Sofer, M. Mandel, T. Buttner, D. Roggenbuck, M. Matucci-Cerinic, K. Danko, M.L. Hoyos and Y. Shoenfeld, A novel automated indirect immunofluorescence autoantibody evaluation, Clin Rheumatol 31 (2012), 503-509
22. I. Knutter, R. Hiemann, T. Brumma, T. Buttner, K. Grossmann, M. Cusini, F. Pregnolato, M.O. Borghi, U. Anderer, K. Conrad, D. Reinhold, D. Roggenbuck and E. Csernok, Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-Associated vasculitis, Arthritis Research & Therapy 14 (2012), R271
23. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970), 680-685
24. M. Lai, E.G. Hughes, X. Peng, L. Zhou, A.J. Gleichman, H. Shu, S. Mata, D. Kremens, R. Vitaliani, M.D. Geschwind, L. Bataller, R.G. Kalb, R. Davis, F. Graus, D.R. Lynch, R. Balice-Gordon and J. Dalmau, AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location, Ann Neurol 65 (2009), 424-434
25. M. Lai, M.G. Huijbers, E. Lancaster, F. Graus, L. Bataller, R. Balice-Gordon, J.K. Cowell and J. Dalmau, Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: A case series, Lancet Neurol 9 (2010), 776-785
26. E. Lancaster, M. Lai, X. Peng, E. Hughes, R. Constantinescu, J. Raizer, D. Friedman, M.B. Skeen, W. Grisold, A. Kimura, K. Ohta, T. Iizuka, M. Guzman, F. Graus, S.J. Moss, R. Balice-Gordon and J. Dalmau, Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: Case series and characterisation of the antigen, Lancet Neurol 9 (2010), 67-76
27. B. Lang and A. Vincent, Autoimmune disorders of the neuromuscular junction, Curr Opin Pharmacol 9 (2009), 336-340
28. D.J. Laurie, I. Bartke, R. Schoepfer, K. Naujoks and P.H. Seeburg, Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies, Brain Res Mol Brain Res 51 (1997), 23-32
29. D. Lavrnic, M. Losen, A. Vujic, B.M. De, L.J. Hajdukovic, V. Stojanovic, R. Trikic, P. Djukic and S. Apostolski, The features of myasthenia gravis with autoantibodies to MuSK, J Neurol Neurosurg Psychiatry 76 (2005), 1099-1102
30. M.I. Leite, P. Strobel, M. Jones, K. Micklem, R. Moritz, R. Gold, E.H. Niks, S. Berrih-Aknin, F. Scaravilli, A. Canelhas, A. Marx, J. Newsom-Davis, N.Willcox and A. Vincent, Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG, Ann Neurol 57 (2005), 444-448
31. J.M. Lindstrom, M.E. Seybold, V.A. Lennon, S. Whittingham and D.D. Duane, Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value, Neurology 26 (1976), 1054-1059
32. M. Manto, J. Dalmau, A. Didelot, V. Rogemond, and J. Honnorat, In vivo effects of antibodies from patients with anti- NMDA receptor encephalitis: Further evidence of synaptic glutamatergic dysfunction, Orphanet J Rare Dis 5 (2010), 31
33. T.U. Mayer, T. Braun and S. Jentsch, Role of the proteasome in membrane extraction of a short-lived ER-transmembrane protein, EMBO J 17 (1998), 3251-3257
34. J. McConville, M.E. Farrugia, D. Beeson, U. Kishore, R. Metcalfe, J. Newsom-Davis and A. Vincent, Detection and characterization of MuSK antibodies in seronegative myasthenia gravis, Ann Neurol 55 (2004), 580-584
35. A.V. Muravyov and I.A. Tikhomirova, Role molecular signaling pathways in changes of red blood cell deformability, Clin Hemorheol Microcirc 53 (2013), 45-59
36. K. Nagasawa, T. Higashi, N. Hosokawa, R.J. Kaufman and K. Nagata, Simultaneous induction of the four subunits of the TRAP complex by ER stress accelerates ER degradation, EMBO Rep 8 (2007), 483-489
37. A. Pevzner, B. Schoser, K. Peters, N.C. Cosma, A. Karakatsani, B. Schalke, A. Melms and S. Kroger, Anti-LRP4 autoantibodies in AChR- and MuSK-Antibody-negative myasthenia gravis, J Neurol 259 (2012), 427-435
38. L.H. Phillips, The epidemiology of myasthenia gravis, Ann N Y Acad Sci 998 (2003), 407-412
39. K. Rezvani, Y. Teng and B.M. De, The ubiquitin-proteasome system regulates the stability of neuronal nicotinic acetylcholine receptors, J Mol Neurosci 40 (2010), 177-184
40. R. Rizzuto, M. Brini, P. Pizzo, M. Murgia and T. Pozzan, Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells, Curr Biol 5 (1995), 635-642
41. R. Rizzuto, H. Nakase, B. Darras, U. Francke, G.M. Fabrizi, T. Mengel, F. Walsh, B. Kadenbach, S. DiMauro and E.A. Schon, A gene specifying subunit VIII of human cytochrome c oxidase is localized to chromosome 11 and is expressed in both muscle and non-muscle tissues, J Biol Chem 264 (1989), 10595-10600
42. W.H. Robinson, C. DiGennaro, W. Hueber, B.B. Haab, M. Kamachi, E.J. Dean, S. Fournel, D. Fong, M.C. Genovese, H.E. De Vegvar, K. Skriner, D.L. Hirschberg, R.I. Morris, S. Muller, G.J. Pruijn, W.J. Van Venrooij, J.S. Smolen, P.O. Brown, L. Steinman and P.J. Utz, Autoantigen microarrays for multiplex characterization of autoantibody responses, Nat Med 8 (2002), 295-301
43. J. Rohde, F. Emschermann, M.R. Knittler, and H.J. Rziha, Orf virus interferes with MHC class I surface expression by targeting vesicular transport and Golgi, BMC Vet Res 8 (2012), 114
44. F. Romi, J.A. Aarli and N.E. Gilhus, Seronegative myasthenia gravis: Disease severity and prognosis, Eur J Neurol 12 (2005), 413-418
45. U. Sack, S. Knoechner, H.Warschkau, U. Pigla, F. Emmrich and M. Kamprad, Computer-Assisted classification of HEp-2 immunofluorescence patterns in autoimmune diagnostics, Autoimmun Rev 2 (2003), 298-304
46. D.B. Sanders, K. El-Salem, J.M. Massey, J. McConville and A. Vincent, Clinical aspects of MuSK antibody positive seronegative MG, Neurology 60 (2003), 1978-1980
47. F. Scuderi, M. Marino, L. Colonna, F. Mannella, A. Evoli, C. Provenzano and E. Bartoccioni, Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement, Laboratory Investigation; a Journal of Technical Methods and Pathology 82 (2002), 1139-1146
48. N.M. Seibel, J. Eljouni, M.M. Nalaskowski and W. Hampe, Nuclear localization of enhanced green fluorescent protein homomultimers, Anal Biochem 368 (2007), 95-99
49. N.M. Sherer, M.J. Lehmann, L.F. Jimenez-Soto, A. Ingmundson, S.M. Horner, G. Cicchetti, P.G. Allen, M. Pypaert, J.M. Cunningham and W. Mothes, Visualization of retroviral replication in living cells reveals budding into multivesicular bodies, Traffic 4 (2003), 785-801
50. J.A. Simpson, Myasthenia Gravis: A new Hypothesis, Scott Med J 5 (1960), 419-436
51. R. Tozzoli, M.C. Sorrentino and N. Bizzaro, Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): A challenge for the autoimmunologist, Immunol Res 56 (2013), 425-431
52. E. Tuzun and J. Dalmau, Limbic encephalitis and variants: Classification, diagnosis and treatment, Neurologist 13 (2007), 261-271
53. E. Tuzun, L. Zhou, J.M. Baehring, S. Bannykh, M.R. Rosenfeld and J. Dalmau, Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma, Acta Neuropathol 118 (2009), 737-743
54. A. Vincent, Unravelling the pathogenesis of myasthenia gravis, Nat Rev Immunol 2 (2002), 797-804
55. A. Vincent, J. McConville, M.E. Farrugia and J. Newsom-Davis, Seronegative myasthenia gravis, Semin Neurol 24 (2004), 125-133
56. A. Watty and S.J. Burden, MuSK glycosylation restrains MuSK activation and acetylcholine receptor clustering, J Biol Chem 277 (2002), 50457-50462
57. N. Yamaguchi and M.N. Fukuda, Golgi retention mechanism of beta-1, 4-galactosyltransferase. Membrane-spanning domain-dependent homodimerization and association with alpha- and beta-tubulins, J Biol Chem 270 (1995), 12170-12176
58. P. Zisimopoulou, P. Evangelakou, J. Tzartos, K. Lazaridis, V. Zouvelou, R. Mantegazza, C. Antozzi, F. Andreetta, A. Evoli, F. Deymeer, G. Saruhan-Direskeneli, H. Durmus, T. Brenner, A. Vaknin, S. Berrih-Aknin, C.M. Frenkian, T. Stojkovic, M. DeBaets, M. Losen, P. Martinez-Martinez, K.A. Kleopa, E. Zamba-Papanicolaou, T. Kyriakides, A. Kostera-Pruszczyk, P. Szczudlik, B. Szyluk, D. Lavrnic, I. Basta, S. Peric, C. Tallaksen, A. Maniaol and S.J. Tzartos, A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis, J Autoimmun 52 (2014), 139-145
59. V. Zouvelou, P. Zisimopoulou, M. Rentzos, N. Karandreas, P. Evangelakou, E. Stamboulis and S.J. Tzartos, Double seronegative myasthenia gravis with anti-LRP 4 antibodies, Neuromuscul Disord 23 (2013), 568-570